Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Prospective Use of Imaging Quantification of Inflammation: Determining Uveitis Activity and Correlating to Visual Acuity
Jordan D Deaner, MD
Updates from the Field
2021
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated With Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
Annual Meeting Talks
2020

Category: Age-Related Macular Degeneration

See more